These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2708556)

  • 21. [Treatment and course of schizophrenic psychoses over a decade. Disease course and predictors].
    Müller P; Günther U; Lohmeyer J
    Nervenarzt; 1986 Jun; 57(6):332-41. PubMed ID: 2874507
    [No Abstract]   [Full Text] [Related]  

  • 22. [The catamnesis of schizophrenics in comparison to previous hospital treatment].
    Efimenko VL; Kabanov MM; Gorelik BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):559-64. PubMed ID: 4267490
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety.
    Rakel RE
    South Med J; 1990 Feb; 83(2):194-8. PubMed ID: 2406933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phenomenology of recovery in a chronic schizophrenic.
    Ratey JJ; Sands S; O'Driscoll G
    Psychiatry; 1986 Nov; 49(4):277-89. PubMed ID: 3809318
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jun; 145(24):1281-3. PubMed ID: 15264758
    [No Abstract]   [Full Text] [Related]  

  • 27. Early antipsychotic response to resumption of neuroleptics in drug-free chronic schizophrenic patients.
    Glovinsky D; Kirch DG; Wyatt RJ
    Biol Psychiatry; 1992 May; 31(9):968-70. PubMed ID: 1637936
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study.
    Bigelow LB; Kirch DG; Braun T; Korpi ER; Wagner RL; Zalcman S; Wyatt RJ
    Psychopharmacol Bull; 1985; 21(1):66-8. PubMed ID: 3983341
    [No Abstract]   [Full Text] [Related]  

  • 29. Buspirone use in an adolescent with social phobia and mixed personality disorder (cluster A type).
    Zwier KJ; Rao U
    J Am Acad Child Adolesc Psychiatry; 1994 Sep; 33(7):1007-11. PubMed ID: 7961339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials.
    Strawn JR; Mills JA; Cornwall GJ; Mossman SA; Varney ST; Keeshin BR; Croarkin PE
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):2-9. PubMed ID: 28846022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A trial of propranolol in chronic schizophrenia.
    Myers DH; Campbell PL; Cocks NM; Flowerdew JA; Muir A
    Br J Psychiatry; 1981 Aug; 139():118-21. PubMed ID: 7030444
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of buspirone in an adolescent with overanxious disorder.
    Kranzler HR
    J Am Acad Child Adolesc Psychiatry; 1988 Nov; 27(6):789-90. PubMed ID: 3198569
    [No Abstract]   [Full Text] [Related]  

  • 33. Ceruletide: a new drug for the treatment of schizophrenic patients?
    Albus M; Ackenheil M; Münch U; Naber D
    Arch Gen Psychiatry; 1984 May; 41(5):528. PubMed ID: 6372739
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients.
    Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Lane HY; Jann MW
    Biol Psychiatry; 1993 Apr; 33(7):557-9. PubMed ID: 8513043
    [No Abstract]   [Full Text] [Related]  

  • 35. Attitudes and behaviors of acute and chronic schizophrenic patients regarding ambulatory treatment.
    Serban G; Thomas A
    Am J Psychiatry; 1974 Sep; 131(9):991-5. PubMed ID: 4369797
    [No Abstract]   [Full Text] [Related]  

  • 36. Antipsychotic effects of ceruletide (caerulein) on chronic schizophrenia.
    Moroji T; Watanabe N; Aoki N; Itoh S
    Arch Gen Psychiatry; 1982 Apr; 39(4):485-6. PubMed ID: 7039550
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of chronic schizophrenia with cyproheptadine: a double-blind placebo-controlled study.
    Silver H; Blacker M; Weller MP; Lerer B
    Biol Psychiatry; 1991 Sep; 30(5):523-5. PubMed ID: 1932400
    [No Abstract]   [Full Text] [Related]  

  • 38. Depressive symptoms and schizophrenia a psychopharmacological approach.
    Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
    Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term buspirone treatment in disinhibition with dementia.
    Tiller JW; Dakis JA; Shaw JM
    Lancet; 1988 Aug; 2(8609):510. PubMed ID: 2900431
    [No Abstract]   [Full Text] [Related]  

  • 40. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
    Udelman HD; Udelman DL
    J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.